Home
Conditions
Osteoporosis, Postmenopausal

Clinical trial condition

Osteoporosis, Postmenopausal

Explore clinical trials studying Osteoporosis, Postmenopausal. Study availability and eligibility vary by location and protocol.

116 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Osteoporosis, Postmenopausal trial results

Enrolling by invitation

Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.

NCT07120854

Conditions: Bone Diseases, Bone Diseases, Metabolic, Diphosphonates, +9 more
Locations: Institut de Recerca Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Active, not recruiting

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

NCT05575167

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Univ. Lille, CHU Lille Lille, France

251 Hellenic Airforce and VA General Hospital Athens, Greece

First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens Athens, Greece

, KAT General Hospital Athens, Greece

View Trial Details

Active, not recruiting

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Hospital for Special Surgery New York, United States

View Trial Details

Active, not recruiting

Romosozumab Use to Build Skeletal Integrity

NCT05058976

Conditions: Bone Diseases, Bone Diseases, Metabolic, Fractures, Bone, +8 more
Locations: UPMC Senior Communities Pittsburgh, Pennsylvania, United States

View Trial Details

Active, not recruiting

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)

NCT05655013

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Active, not recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

NCT03623633

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

NCT03692143

Conditions: Back Injuries, Bone Diseases, Bone Diseases, Metabolic, +11 more
Locations: Not specified

View Trial Details

Completed

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

NCT07242612

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Northwest General Hospital Peshawar, Khyber Pakhtunkhwa, Pakistan

View Trial Details

Completed

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

NCT05493761

Conditions: Bone Diseases, Bone Diseases, Metabolic, Digestive System Diseases, +13 more
Locations: Department of Endocrinology, "Hippokration" General Hospital of Thessaloniki Thessaloniki, Greece

1st Department of Obstetrics and Gynecology, School, of Medicine, Aristotle University of Thessaloniki Thessaloniki, Greece

424 General Military Hospital Thessaloniki, Greece

View Trial Details

Completed

Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

NCT07717788

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: AL-KUFA UNIVERSITY/College of Pharmacy Najaf, Iraq

View Trial Details

Osteoporosis, Postmenopausal

Osteoporosis, Postmenopausal trial results

Related conditions